13.1 Pharmacology Overview

13.1 Pharmacology Overview

Ophthalmic pharmacology is the study of drugs applied to or affecting the eye. On the Certified Ophthalmic Assistant (COA) exam administered by IJCAHPO (International Joint Commission on Allied Health Personnel in Ophthalmology) at Pearson VUE, pharmacology is approximately 6% of the roughly 200 scored multiple-choice questions you answer in a 3-hour sitting. That weight is small but high-yield: pharmacology questions are concrete, factual, and easy points if you have memorized drug classes, concentrations, and side effects.

What the COA must know

As an assistant you do not prescribe, but you routinely prepare, instill, document, and monitor topical agents under physician direction. The exam expects you to recognize each drug by class, mechanism, indication, concentration, onset, duration, and key adverse effect.

The core diagnostic drug classes

Mydriasis vs. cycloplegia (a classic distractor)

These terms are tested constantly and confused easily. Mydriasis is pupil dilation (the dilator pulls the iris open). Cycloplegia is paralysis of the ciliary muscle, which stops accommodation and produces blurred near vision. Phenylephrine causes pure mydriasis; it does NOT cycloplege. Tropicamide and cyclopentolate do both, but tropicamide is a relatively weak cycloplegic, which is why pediatric refraction relies on stronger cyclopentolate or atropine.

A worked example

A 7-year-old needs a cycloplegic refraction to uncover latent hyperopia. Tropicamide alone is insufficient because children have powerful accommodation. The physician orders cyclopentolate 1%, which gives reliable cycloplegia in 30-60 minutes. If the child were under 1 year, a lower concentration (cyclopentolate 0.5%) reduces systemic anticholinergic risk. The COA must know cyclopentolate can rarely cause CNS effects in children (ataxia, disorientation, drowsiness), so you observe the child afterward.

Trap to avoid

Do not assume "dilation" always means the same drop. The physician selects the agent based on the goal: quick exam dilation (tropicamide + phenylephrine), refraction (cyclopentolate), or therapeutic dilation to break a synechia (atropine, longest-acting). Read the stem for the clinical purpose before choosing the drug.

How drugs reach the eye

The COA should understand basic ophthalmic routes of administration, because the exam contrasts them. Topical drops and ointments are the most common; ointments stay longer but blur vision, so they are often reserved for bedtime. Subconjunctival and intravitreal injections deliver high local concentrations (anti-VEGF agents for macular degeneration are intravitreal). Oral and intravenous routes (acetazolamide, fluorescein angiography dye) act systemically. Periocular depot injections give prolonged delivery.

The eye's tear film and blink reflex wash most of a drop away within minutes, which is exactly why punctal occlusion and waiting between drops matter.

Reading a drug label

Every ophthalmic bottle states the active ingredient, concentration as a percentage, and the cap color convention used in the United States. Concentration is meaningful: phenylephrine 2.5% and 10% are very different drugs in terms of safety, and proparacaine 0.5% is the standard anesthetic strength. The COA verifies the label every time rather than relying on cap color alone, because look-alike bottles are a real source of error. When two answer choices name the same drug at different strengths, the safer or clinically appropriate concentration is usually correct.

Documentation expectations

Whenever you instill a drug, you record the agent, concentration, eye (OD = right, OS = left, OU = both), and time. Accurate timing matters because the physician needs to know dilation is adequate (about 20-30 minutes for tropicamide-phenylephrine) before examining the fundus. Sloppy documentation is a common distractor in scenario questions: the "best" answer instills correctly and records it.

Scope of practice for the assistant

The COA works under physician supervision and within delegated authority. You may instill diagnostic drops, perform dilation per protocol, and educate patients, but you do not independently diagnose, prescribe, or change a medication regimen. When a scenario describes a patient asking you to "just adjust" or "refill" a prescription, the safe answer routes the request to the physician. Recognizing the boundary between an assistant's delegated tasks and the physician's prescribing role is tested both here and in the ethics and patient-services domains.

Generic vs. brand and patient education

Patients often present a medication list mixing brand and generic names, and the COA should recognize common pairs: latanoprost (Xalatan), timolol (Timoptic), brimonidine (Alphagan), dorzolamide-timolol combinations (Cosopt), and prednisolone acetate (Pred Forte). Reconciling these accurately prevents duplicate-therapy errors. Patient education is part of the role too: teach correct drop technique, punctal occlusion, waiting between drops, and the importance of finishing an antibiotic course or not abruptly stopping glaucoma drops, since lapses raise IOP.

A well-instructed patient is a recurring "best answer" theme because adherence directly affects outcomes.